Study Stopped
Insufficient funds
Insufficient funds
Sponsor study identifier
observational
0
0 countries
N/A
Study Start
October 18, 2016
Actual (reported)Primary Completion
July 13, 2017
Actual (reported)Study Completion
July 13, 2017
Actual (reported)Cardiovascular disease is one of the leading causes of death in the United States and the world. Many interventions relating to prevention have been emphasized as more risk factors for this devastating disease are discovered. Periodontal disease is known to have a close association with cardiovascular disease, but its role as a risk factor is still not well understood. Inflammation is a driving force in both of these diseases, creating a potential bridge between the two. Specifically, periodontal disease can cause an inflammatory reaction in the body, which may predispose or even directly contribute to atheroma formation in the coronary arteries. In this study, the investigators will study the link between the inflammatory state of the body and will search for a correlation with levels of coronary artery disease and periodontal disease. Inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), and immunoglobulin G (IgG) levels in the patient's blood will be analyzed and correlated to clinical attachment loss measured via pocket depth measurement, the distance from the gingival margin to the base of the pocket. A definitive link between these disease processes will allow preventive measures to be taken earlier to prevent this lifelong disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 13, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 18, 2016
Actual (reported)January 26, 2017
Actual (reported)February 3, 2017
Actual (reported)July 13, 2017
Actual (reported)July 13, 2017
Actual (reported)Level of periodontal disease
one day
ESR
one day
Myeloperoxidase (MPO)
one day
IgG
one day
hs-CRP
one day
Patients with no known cardiovascular disease.
Patients with cardiovascular disease without a myocardial infarction.
Patients with cardiovascular disease with previous history of a myocardial infarction.
A periodontal probe will be inserted between the tooth and the gum in the gingival sulcus and a measurement of the pocket depth will be measured by a trained dentist in all subjects
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All patients from ages 18-89 years who are being seen in the Center for Cardiovascular Health at TTUHSC and at Dr. Johnson's dental clinic who meet the inclusion criteria, and who will consent to participating in the study. There will be between 25 to 35 patients in each group.
Ami Knox, MBA
Texas Tech University Health Sciences Center
0 participants (actual enrollment reported by the registry).
First Submitted
January 26, 2017
First Posted
February 3, 2017
Study Start
October 18, 2016
Actual (reported)Association of Asprosin in Periodontitis and Acute Coronary Syndrome
Contact the study team to confirm eligibility.
Primary Completion
July 13, 2017
Actual (reported)Study Completion
July 13, 2017
Actual (reported)Last Updated
January 30, 2020
Record last verified: 2020-01
Data will not be shared with other researchers
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: